Andy Nguyen, M.D. / UT-Medical School at Houston, Pathology/ Last Revision on: 3/6/2017


Stains Phrase (Used for 88312 and 88313) and Disclaim Phrase (88342):


The positive controls and internal negative controls for the special stains have been reviewed, and appropriate staining is confirmed by the pathologist whose signature appears above.


Some of the immunohistochemical tests in this panel were developed and their performance characteristics determined by Memorial Hermann Southwest Hospital Laboratory.  They have not been cleared or approved by the U. S. Food and Drug Administration.  The FDA has determined that such clearance or approval is not necessary.  These tests are used for clinical purposes.  They should not be regarded as investigational or for research.  This laboratory is regulated under the Clinical Laboratory Improvement Amendments of the 1988 (CLIA) as qualified to perform high complexity clinical testing. 


QA Consensus Phrase:

Comment :

-This case was reviewed with a consensus in the University of Texas-Houston Medical School Hematopathology QA Conference on xx/xx/xxxx.


Quick Keys (in PathNet):

 Bone Marrow Stain Phrase: BMU F9

Flow Cytometry Template: LYM F9

Bone Marrow Synoptic: TSBM F9

Bone Marrow Myeloma: TSPCBM F9

Lymph Node Synoptic: TSLYM F9